Mitochondrial Cardiomyopathy: Distinctive Cardiac Phenotype Detected with Cardiovascular MRI
Stephan A C Schoonvelde1, Claudine W B Ruijmbeek1, Judith M A Verhagen1
1Departments of Cardiology (S.A.C.S., M.M., A.H.), Clinical Genetics (C.W.B.R., J.M.A.V.), and Radiology and Nuclear Medicine (A.H.), Erasmus Medical Center, University Medical Center Rotterdam, Doctor Molewaterplein 40, Room Rg-419, 3015 GD Rotterdam, the Netherlands; Department of Clinical Genetics, Maastricht University Medical Center, Maastricht, the Netherlands (D.M.E.I.H.); and Department of Cardiology, Albert Schweitzer Hospital, Dordrecht, the Netherlands (M.J.M.K.).
Mitochondrial DNA variants can cause left ventricular hypertrophy (LVH). Cardiac MRI revealed a consistent, distinctive phenotype of extensive LVH, dilatation, and decreased ejection fraction in three siblings with an MT-TI gene variant.
Area of Science:
- Cardiology
- Genetics
- Radiology
Background:
- Left ventricular hypertrophy (LVH) presents a wide differential diagnosis.
- Mitochondrial DNA (mtDNA) pathogenic variants are an uncommon etiology of LVH.
- Cardiac magnetic resonance (CMR) imaging is crucial for diagnosing rare causes of cardiac conditions.
Observation:
- This case report details three siblings harboring a pathogenic variant in the mitochondrially encoded tRNA isoleucine (MT-TI) gene.
- A distinct cardiac phenotype was identified using cardiac MR imaging.
- All three siblings exhibited a consistent pattern of extensive LVH, cardiac dilatation, and reduced ejection fraction.
Findings:
- Cardiac MRI demonstrated increased T2 signal and widespread late gadolinium enhancement in affected siblings.
- The observed cardiac phenotype was remarkably uniform across the three affected individuals.
- Genetic analysis confirmed a pathogenic variant in the MT-TI gene as the underlying cause.
Implications:
- This case highlights the role of cardiac MRI in identifying rare inherited cardiomyopathies.
- Understanding this specific MT-TI gene variant's cardiac manifestation aids in diagnosis and management.
- Early identification of genetic cardiomyopathies through advanced imaging can guide personalized treatment strategies.
More Related Videos
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Mitral Stenosis II: Clinical features and Diagnostic Tests
Imaging Studies for Cardiovascular System IV: CMRI
Cardiomyopathy IV: Restrictive Cardiomyopathy
Imaging Studies for Cardiovascular System III: X-Ray
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
Cardiomyopathy I: Introduction and Classification


